TY - JOUR
T1 - Comparative actions of monomethoxy amphetamines on the release and uptake of biogenic amines in brain tissue
AU - Tseng, L. F.
AU - Menon, M. K.
AU - Loh, H. H.
PY - 1976/1/1
Y1 - 1976/1/1
N2 - para Methoxyamphetamine (PMA), a known hallucinogen, is the most potent compound among methoxyamphetamines in disrupting behavior in rats. PMA, unlike d amphetamine (A), did not induce stereotyped behavior and was less effective than A in stimulation of locomotor d amphetamine like effects, but ortho methoxyamphetamine (OMA) was devoid of any locomotor stimulation. To investigate the reasons for the different behavioral effects caused by PMA, meta methoxyamphetamine (MMA), OMA and A, a comparison was made among these drugs on the release and uptake of 3H 5 hydroxytryptamine (3H 5 HT), 3H norepinephrine (3H NE) and 3H dopamine (3H DA) in tissue slices of cerebral cortex and corpus striatum of rat brain. The potencies for the increased release of 3H 5 HT were found to be PMA > MMA ≥ A > OMA in cerebral cortex, of 3H NE in cortex, A ≥ PMA = MMA > OMA, and of 3H DA in corpus striatum, A > MMA > PMA ≥ OMA. The potencies for inhibiting the uptake of 3H 5 HT in cerebral cortex and corpus striatum were found to be PMA > MMA > A > OMA and of 3H NE in cortex A > PMA ≥ MMA > OMA, and 3H DA in corpus striatum A > MMA > PMA > OMA. d PMA is equipotent to l PMA in increasing the release of 3H 5 HT but is more potent than l PMA in blocking the uptake of 3H 5 HT. The high potency of PMA on increasing the release and inhibiting the uptake of 5 HT suggests that 5 HT may be involved in the production of hallucinogenic effects of PMA.
AB - para Methoxyamphetamine (PMA), a known hallucinogen, is the most potent compound among methoxyamphetamines in disrupting behavior in rats. PMA, unlike d amphetamine (A), did not induce stereotyped behavior and was less effective than A in stimulation of locomotor d amphetamine like effects, but ortho methoxyamphetamine (OMA) was devoid of any locomotor stimulation. To investigate the reasons for the different behavioral effects caused by PMA, meta methoxyamphetamine (MMA), OMA and A, a comparison was made among these drugs on the release and uptake of 3H 5 hydroxytryptamine (3H 5 HT), 3H norepinephrine (3H NE) and 3H dopamine (3H DA) in tissue slices of cerebral cortex and corpus striatum of rat brain. The potencies for the increased release of 3H 5 HT were found to be PMA > MMA ≥ A > OMA in cerebral cortex, of 3H NE in cortex, A ≥ PMA = MMA > OMA, and of 3H DA in corpus striatum, A > MMA > PMA ≥ OMA. The potencies for inhibiting the uptake of 3H 5 HT in cerebral cortex and corpus striatum were found to be PMA > MMA > A > OMA and of 3H NE in cortex A > PMA ≥ MMA > OMA, and 3H DA in corpus striatum A > MMA > PMA > OMA. d PMA is equipotent to l PMA in increasing the release of 3H 5 HT but is more potent than l PMA in blocking the uptake of 3H 5 HT. The high potency of PMA on increasing the release and inhibiting the uptake of 5 HT suggests that 5 HT may be involved in the production of hallucinogenic effects of PMA.
UR - http://www.scopus.com/inward/record.url?scp=0017098415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0017098415&partnerID=8YFLogxK
M3 - Article
C2 - 1271280
AN - SCOPUS:0017098415
SN - 0022-3565
VL - 197
SP - 263
EP - 271
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -